X

Trial Profile

CALGB 80101 (CINJ 070406): Phase III Randomized Study of Adjuvant Chemoradiation After Resection in Patients With Gastric or Gastroesophageal Adenocarcinoma.

Status: Active, no longer recruiting

Phase of Trial: Phase III

Latest Information Update: 18 Sep 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Cisplatin; Epirubicin; Fluorouracil; Folinic acid
Indications Gastric cancer; Oesophageal cancer
Focus Biomarker; Therapeutic Use

Most Recent Events

07 May 2020 Biomarkers information updated
07 Jun 2011 Results presented at the 47th Annual Meeting of the American Society of Clinical Oncology.
08 Apr 2011 Planned end date changed from 29 May 2009 to 1 Jun 2017 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com